Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenny J Watson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 2011
Application of physiologically based pharmacokinetic modeling to understanding the clinical pharmacokinetics of UK-369,003Kenny J Watson, John Davis, Hannah M Jones
The AAPS Journal|March 13, 2009
Modelling and PBPK simulation in drug discoveryHannah M Jones, Iain B Gardner, Kenny J Watson
Toxicology and Applied Pharmacology|June 1, 2015
Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety modelAlexandre Trifilieff, Brian T Ethell, David A Sykes, et al.
Journal of Pharmacological and Toxicological Methods|March 23, 2011
Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeysKenny J Watson, William P Gorczyca, John Umland, et al.
Clinical Pharmacology and Therapeutics|October 23, 2021
Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime-Avibactam in Pediatric Patients Aged 3 Months and OlderRichard C Franzese, Lynn McFadyen, Kenny J Watson, et al.
Clinical Pharmacokinetics|April 5, 2011
Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modellingHannah M Jones, Iain B Gardner, Wendy T Collard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 2011
Application of physiologically based pharmacokinetic modeling to understanding the clinical pharmacokinetics of UK-369,003Kenny J Watson, John Davis, Hannah M Jones
The AAPS Journal|March 13, 2009
Modelling and PBPK simulation in drug discoveryHannah M Jones, Iain B Gardner, Kenny J Watson
Toxicology and Applied Pharmacology|June 1, 2015
Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety modelAlexandre Trifilieff, Brian T Ethell, David A Sykes, et al.
Journal of Pharmacological and Toxicological Methods|March 23, 2011
Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeysKenny J Watson, William P Gorczyca, John Umland, et al.
Clinical Pharmacology and Therapeutics|October 23, 2021
Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime-Avibactam in Pediatric Patients Aged 3 Months and OlderRichard C Franzese, Lynn McFadyen, Kenny J Watson, et al.
Clinical Pharmacokinetics|April 5, 2011
Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modellingHannah M Jones, Iain B Gardner, Wendy T Collard, et al.
Pageof 1